Summary
Signal counts
Assets tracked: 2
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT01896856 | https://clinicaltrials.gov/study/NCT04363164 | https://clinicaltrials.gov/study/NCT06100705
Assets
Linked programs
- SGI-110 Dose Escalation: Low Signal (1/5)
- Testosterone cypionate: Watchlist Signal (2/5)